Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study
- PMID: 22193396
- DOI: 10.1590/s0066-782x2011005000095
Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study
Abstract
Background: The injection of stem cells in the context of acute myocardial infarction (AMI) has been tested almost exclusively by anterograde intra-arterial coronary (IAC) delivery. The retrograde intravenous coronary (IVC) delivery may be an additional route.
Objective: To compare the cell distribution and retention pattern in the anterograde and retrograde routes. To investigate the role of microvascular obstruction by magnetic resonance imaging in cell retention by cardiac tissue after the injection of bone marrow mononuclear cells (BMMC) in AMI.
Methods: This was a prospective, open label, randomized study. Patients with AMI who presented: (1) successful chemical or mechanical reperfusion within 24 hours of symptom onset and (2) infarction involving more than 10% of the left ventricle (LV) at the myocardial scintigraphy were included in the study. One hundred million BMMC were injected into the infarction-related artery through IAC route, or vein through the IVC route. One percent of the injected cells were labeled with 99mTc-hexamethyl-propylene-amine-oxime (99mTc-HMPAO). Cell distribution was evaluated at 4 and 24 hours after the myocardial scintigraphy injection. Cardiac magnetic resonance imaging was performed before cell injection.
Results: Thirty patients were randomized into three groups. There were no serious adverse events related to the procedure. The early and late retention of labeled cells was higher in the IAC group than in IVC group, regardless of the presence of microcirculation obstruction.
Conclusion: The injection using the retrograde approach was feasible and safe. Cell retention by cardiac tissue was higher using the anterograde approach. More studies are needed to confirm these findings.
Similar articles
-
Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques.Cell Transplant. 2009;18(3):343-52. doi: 10.3727/096368909788534951. Cell Transplant. 2009. PMID: 19558782 Clinical Trial.
-
Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution.Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E17-25. doi: 10.1002/ccd.24659. Epub 2013 Oct 7. Catheter Cardiovasc Interv. 2014. PMID: 22972685 Free PMC article.
-
One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction.Heart. 2007 Jul;93(7):837-41. doi: 10.1136/hrt.2006.091934. Epub 2007 Feb 19. Heart. 2007. PMID: 17309910 Free PMC article.
-
[Stem cell therapy in acute myocardial infarction].Internist (Berl). 2008 Sep;49(9):1068-78. doi: 10.1007/s00108-008-2079-y. Internist (Berl). 2008. PMID: 18668218 Review. German.
-
Choice of cell-delivery route for successful cell transplantation therapy for the heart.Future Cardiol. 2013 Mar;9(2):215-27. doi: 10.2217/fca.12.85. Future Cardiol. 2013. PMID: 23463974 Review.
Cited by
-
Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model.Int J Nanomedicine. 2014;9:17-26. doi: 10.2147/IJN.S52005. Epub 2013 Dec 11. Int J Nanomedicine. 2014. PMID: 24376353 Free PMC article.
-
No-reflow reversibility: a study based on serial assessment of multiple biomarkers.J Cardiovasc Transl Res. 2013 Oct;6(5):798-807. doi: 10.1007/s12265-013-9509-5. Epub 2013 Sep 6. J Cardiovasc Transl Res. 2013. PMID: 24008841
-
Cell delivery routes for stem cell therapy to the heart: current and future approaches.J Cardiovasc Transl Res. 2012 Oct;5(5):713-26. doi: 10.1007/s12265-012-9378-3. Epub 2012 May 31. J Cardiovasc Transl Res. 2012. PMID: 22648235 Review.
-
Stem Cell Therapy for the Treatment of Myocardial Infarction: How Far Are We Now?Cureus. 2021 Aug 9;13(8):e17022. doi: 10.7759/cureus.17022. eCollection 2021 Aug. Cureus. 2021. PMID: 34522503 Free PMC article. Review.
-
In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine.Stem Cells Int. 2016;2016:3140120. doi: 10.1155/2016/3140120. Epub 2016 Jan 12. Stem Cells Int. 2016. PMID: 26880951 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical